Omnicell, Inc. (NASDAQ:OMCL) Receives $44.83 Average PT from Brokerages

Omnicell, Inc. (NASDAQ:OMCL - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the seven analysts that are currently covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $44.83.

OMCL has been the topic of a number of recent analyst reports. Benchmark cut their price target on shares of Omnicell from $62.00 to $40.00 and set a "buy" rating on the stock in a report on Wednesday, May 7th. JPMorgan Chase & Co. cut their price target on shares of Omnicell from $44.00 to $36.00 and set a "neutral" rating on the stock in a report on Thursday, March 20th. Wells Fargo & Company restated an "overweight" rating and set a $37.00 price target (up previously from $35.00) on shares of Omnicell in a report on Friday, May 23rd. Wall Street Zen upgraded shares of Omnicell from a "hold" rating to a "buy" rating in a report on Tuesday, May 20th. Finally, Bank of America boosted their price target on shares of Omnicell from $30.00 to $34.00 and gave the company a "neutral" rating in a report on Friday, May 23rd.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in OMCL. KBC Group NV grew its position in Omnicell by 60.8% during the fourth quarter. KBC Group NV now owns 2,057 shares of the company's stock valued at $92,000 after purchasing an additional 778 shares in the last quarter. SteelPeak Wealth LLC purchased a new position in Omnicell during the fourth quarter valued at approximately $635,000. Sumitomo Mitsui Trust Group Inc. grew its position in Omnicell by 93.3% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,450,416 shares of the company's stock valued at $64,573,000 after purchasing an additional 699,925 shares in the last quarter. Empowered Funds LLC purchased a new position in Omnicell during the fourth quarter valued at approximately $388,000. Finally, Shaker Investments LLC OH purchased a new position in Omnicell during the fourth quarter valued at approximately $550,000. 97.70% of the stock is owned by hedge funds and other institutional investors.

Omnicell Price Performance

Shares of NASDAQ OMCL traded up $0.39 during midday trading on Wednesday, reaching $30.22. The company's stock had a trading volume of 756,716 shares, compared to its average volume of 569,878. The company has a current ratio of 1.37, a quick ratio of 1.22 and a debt-to-equity ratio of 0.13. The company has a 50 day moving average price of $30.42 and a 200 day moving average price of $38.02. Omnicell has a one year low of $22.66 and a one year high of $55.75. The company has a market cap of $1.42 billion, a price-to-earnings ratio of 111.93, a price-to-earnings-growth ratio of 7.53 and a beta of 0.78.

Omnicell (NASDAQ:OMCL - Get Free Report) last released its earnings results on Tuesday, May 6th. The company reported $0.26 EPS for the quarter, topping analysts' consensus estimates of $0.16 by $0.10. Omnicell had a net margin of 1.13% and a return on equity of 3.82%. The business had revenue of $269.67 million for the quarter, compared to the consensus estimate of $260.18 million. During the same period in the previous year, the firm earned $0.03 EPS. The business's revenue for the quarter was up 9.5% on a year-over-year basis. On average, equities research analysts expect that Omnicell will post 1.09 EPS for the current year.

Omnicell Company Profile

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.